Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-08-25FDA Approved: PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' original application for a generic Promethazine hydrochloride and phenylephrine hydrochloride product.
-
CLINICAL_TRIALS trial_result · 2009-08-25Clinical Trial Update: Oral Bacteria and Allergic Disease in Children
A NIEHS-sponsored trial investigating oral bacteria and allergic disease in children has completed. The study covered asthma, allergic rhini…
-
FDA approval · 2009-08-21FDA Approved: XYZAL — Supplemental Application (Chattem, Inc.)
FDA has approved a supplemental application for XYZAL (levocetirizine dihydrochloride) submitted by Chattem, Inc., effectively granting appr…
-
FDA approval · 2009-08-19FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Singulair (montelukast) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2009-08-19Clinical Trial Update: Singulair(R) In Asthma And Allergic Rhinitis (0476-383) [Phase 4]
Phase 4 clinical trial update on Singulair (montelukast) in asthma, with indications for allergic rhinitis noted; results posted in 2009 and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-08-11Clinical Trial Update: Response of Desloratadine Syrup in the Relief of Symptoms Associated With Perennial Allergic Rhinitis in Pediatric Patients (Study P04299)
Clinical trial updating pediatric response to desloratadine syrup for perennial allergic rhinitis; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2009-08-06Clinical Trial Update: Efficacy and Safety Trial of SLITone(TM) Birch in Subjects With Hayfever [Phase 3]
Phase 3 trial assessing the efficacy and safety of SLITone Birch for allergic rhinitis (hay fever) has completed, with results posted on 200…
-
CLINICAL_TRIALS trial_result · 2009-08-06Clinical Trial Update: Safety of Aerius Syrup in Pediatric Patients Aged 1-5 Years Old With Allergic Rhinitis or Chronic Idiopathic Urticaria (Study P04446AM1)(COMPLETED)
A completed pediatric safety study of Aerius syrup in children 1-5 years with allergic rhinitis or chronic idiopathic urticaria; results pos…
-
FDA approval · 2009-08-03FDA Approved: AZELASTINE HYDROCHLORIDE — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s azelastine hydrochloride generic under an Original Application.
-
FDA approval · 2009-07-30FDA Approved: NASAL ALLERGY — Original Application (Kroger Company)
FDA approved NASAL ALLERGY with triamcinolone acetonide from Kroger Company as an Original Application (ANDA 078104) for allergic rhinitis.
-
FDA approval · 2009-07-28FDA Approved: FLONASE SENSIMIST ALLERGY RELIEF — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for Flonase Sensimist Allergy Relief (fluticasone furoate) from Haleon US Holdings LLC. The approval…
-
CLINICAL_TRIALS trial_result · 2009-07-17Clinical Trial Update: Evaluation of Desloratadine When Used in Patients With Either Allergic Rhinitis or Chronic Idiopathic Urticaria
A completed clinical trial evaluating desloratadine in patients with allergic rhinitis or chronic idiopathic urticaria; results posted in 20…
-
CLINICAL_TRIALS trial_result · 2009-06-22Clinical Trial Update: Allergen Challenge Chamber Study With Single Dose Intranasal GSK1004723 Compared With Placebo [Phase 2]
Phase 2 allergen challenge trial comparing single-dose intranasal GSK1004723 to placebo in allergic rhinitis has completed.
-
FDA approval · 2009-06-10FDA Approved: DIPHENHYDRAMINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for diphenhydramine hydrochloride (PAI Pharma) under an ANDA.
-
CLINICAL_TRIALS research · 2009-06-09Clinical Trial Update: Nasal Epithelium Gene Expression Profiling in Child Respiratory Allergic Disease [NA]
A completed clinical trial update focusing on nasal epithelial gene expression profiling in children with allergic rhinitis.
-
FDA approval · 2009-05-28FDA Approved: ALLERGY RELIEF CHILDRENS — Supplemental Application (CVS Pharmacy)
FDA approved a supplemental application for ALLERGY RELIEF CHILDRENS containing cetirizine hydrochloride by CVS Pharmacy.
-
FDA approval · 2009-05-28FDA Approved: CHILDRENS CETIRIZINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Children's Cetirizine Hydrochloride from Sun Pharmaceutical Industries, Inc., under an ANDA subm…
-
FDA approval · 2009-05-19FDA Approved: ADVIL ALLERGY SINUS — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Advil Allergy Sinus, a multi-ingredient combination product from Haleon US Holdings LLC.
-
CLINICAL_TRIALS trial_result · 2009-05-13Clinical Trial Update: Study Of Allergic Rhinitis In Patients Who Also Have Asthma [Phase 4]
Phase 4 clinical trial update by GlaxoSmithKline studying allergic rhinitis in patients with asthma; the study is completed and results were…
-
FDA approval · 2009-04-30FDA Approved: AZELASTINE HYDROCHLORIDE — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s original application for azelastine hydrochloride, a generic antihistamine product.
-
CLINICAL_TRIALS trial_result · 2009-04-29Clinical Trial Update: Safety and Tolerability Study of rBet v1 SLIT Tablets [Phase 1]
Phase 1 safety and tolerability study of recombinant Bet v 1 sublingual immunotherapy tablets (rBet v1 SLIT) in individuals with birch polle…
-
FDA approval · 2009-04-27FDA Approved: CETIRIZINE HYDROCHLORIDE ORAL SOLUTION — Original Application (APOZEAL PHARMACEUTICALS INC)
FDA approved Apozeal Pharmaceuticals' cetirizine hydrochloride oral solution as an original generic product.
-
FDA approval · 2009-04-23FDA Approved: CLARITIN-D 12 HOUR — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin-D 12 Hour, a loratadine and pseudoephedrine sulfate combination product from Bayer Heal…
-
FDA approval · 2009-04-06FDA Approved: CLARITIN LIQUI-GELS — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin Liqui-Gels (loratadine) submitted by Bayer HealthCare LLC, pertaining to this formulati…
-
CLINICAL_TRIALS trial_result · 2009-04-06Clinical Trial Update: Normal Values of Facial Thermography
The trial has completed and reports normal facial thermography values in healthy participants and those with allergic conditions, including …